Your browser doesn't support javascript.
loading
Evaluating the Time to Palliative Care Referrals in Patients With Small-Cell Lung Cancer: A Single-Centre Retrospective Review.
Watson, Geoffrey Alan; Saunders, Jean; Coate, Linda.
Afiliação
  • Watson GA; 1 Department of Medical Oncology, University Hospital Limerick, Limerick, Ireland.
  • Saunders J; 2 Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland.
  • Coate L; 1 Department of Medical Oncology, University Hospital Limerick, Limerick, Ireland.
Am J Hosp Palliat Care ; 35(11): 1426-1432, 2018 Nov.
Article em En | MEDLINE | ID: mdl-29739231
ABSTRACT

INTRODUCTION:

Lung cancer is a leading cause of morbidity and mortality worldwide. Patients with lung cancer may experience a plethora of symptoms, which can be debilitating and affect their quality of life. Palliative care input to manage their physical and psychological well-being is a crucial component of their oncological care. The benefit of early palliative care input has been shown in patients with non-small cell lung cancer; however, data pertaining to patients with small-cell lung cancer are scarce. Nevertheless, early palliative care input is recommended by several national and international guidelines. Thus, we aimed to assess the time to palliative care referrals in patients diagnosed with small-cell lung cancer in an Irish tertiary hospital and to determine what impact this had on overall survival.

METHODS:

We performed a retrospective, single-center audit of all patients diagnosed with extensive stage small-cell lung cancer over a 6-year period in an Irish tertiary hospital.

RESULTS:

Overall, 91 patients were identified. Median age at diagnosis was 66 years (range 38-83 years). The median Eastern Cooperative Oncology Group Performance Status at diagnosis was 1 (range 0-3); 24 (26%) patients had multiple sites of distant metastasis at diagnosis; 45 (49.5%) patients were alive at 6 months, and 15 (16.5%) patients were alive at 12 months. One hundred percent of patients received palliative care input in our center over the course of their care. In the patients alive at 6 months after diagnosis, there was no survival advantage in those receiving palliative care within 1 month ( P = .002, odd ratio 0.23, 95% confidence interval 0.09-0.59).

CONCLUSION:

Palliative care treatment is a critical aspect in the oncological treatment of all patients diagnosed with advanced cancer, and this study highlights good compliance with existing national guidelines. Further research focusing on quality-of-life issues with the use of questionnaires to assess physical and psychological symptoms should be performed to further understand the impact of palliative care in these patients.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Cuidados Paliativos / Encaminhamento e Consulta / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Am J Hosp Palliat Care Assunto da revista: ENFERMAGEM Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Cuidados Paliativos / Encaminhamento e Consulta / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Am J Hosp Palliat Care Assunto da revista: ENFERMAGEM Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irlanda